DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Indo Rama Synthetics (India) Limited — Press Release

NSE 1 hr ago·16 Oct 2026, 1:50 pm

Indo Rama Synthetics

Indo Rama Synthetics (India) Limited has informed stock exchanges about a press release scheduled for October 16, 2026. The company has not yet disclosed the specific content of this communication to the public.

For investors, this announcement signals that the company is preparing to share material information with the market. Such releases often relate to corporate updates, strategic initiatives, or significant financial developments that could impact the stock's performance.

Investors should wait for the official release to understand the full context. Until then, market participants should avoid making hasty decisions based solely on this notification and monitor the company's official filings for clarity.